1 / 17

Wed review

Wed review. Ion channels—characteristics? K + channel How is selectivity for K + conferred? Na + channel What opens the channel? nACh receptor channel What conformational change is necessary to open the channel? Biosignaling/signal transduction What are common characteristics?

tamara-burgess
Download Presentation

Wed review

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Wed review • Ion channels—characteristics? • K+ channel • How is selectivity for K+ conferred? • Na+ channel • What opens the channel? • nACh receptor channel • What conformational change is necessary to open the channel? • Biosignaling/signal transduction • What are common characteristics? • Gated ion channels • Neuronal signaling • Facilitated by release of neurotransmitters (like ACh)

  2. Signaling in nervous system • Neurons carry nerve impulse (action potential) from one end of cell (cell body) through elongated extension (axon) • Impulse triggers neurotransmitter (ACh) release into post-synaptic cleft • NT (ACh) carries signal to adjacent cell/neuron

  3. Biosignaling in the nervous system—gated ion channels • nACh receptor • 3 conformations • No ligand closed ‘resting’ state • ACh  open ‘excited’ • Na+ and Ca+2 flow • ACh for a long time  closed ‘desensitized’

  4. Biosignaling in the nervous system—nACh receptor • Resting state Vm = -60 mV • nACh receptors, Na+ channels, K+ channels, Ca+2 channels are closed • ACh released by excited neuron • Diffusion synaptic cleft • Interacts with ACh receptor on next neuron • Channel opens and Na+ and Ca+2 pass • Depolarizes the membrane to –40 mV

  5. Biosignaling in the nervous system—Na+, K+ channels • In response to membrane depolarization ( –40 mV) • Na+ channels open • Na+ in further depolarizes the cell locally • Vm increases to +30 mV • Na+ channels close • K+ channels open (response to large depolarization) • K+ out repolarizes the cell locally • Vm returns to negative • K+ channels close

  6. Biosignaling in the nervous system • ‘Wave’ of depolarization pulse travels down axon of neuron • opening and closing of Na+ and K+ channels • Distal tip of axon • Ca+2 channels open in response to depolarization • Ca+2 in, causing release of ACh from vesicles • ACh binds to receptors on adjacent neuron ….. • What happens when we inhibit system?

  7. Toxins/inhibitors • Na+ channel inhibition • Tetrodotoxin • Saxitoxin • AChreceptor inhibition • Tubocurarine • Cobratoxin • a-bungarotoxin • Block signals nerves  muscles • Paralysis and death

  8. Toxins • Clostridium botulinum • Botulism • Inhibition ACh release • Respiratory paralysis (in serious cases) • a-latrotoxin (black widow) • Abnormal release of ACh • Rarely fatal • Nausea, mild paralysis

  9. Receptor Enzymes • 2 functional domains • Extracellular ligand binding • Intracellular enzyme active site • 2 most common • ***Tyr-kinase enzymes • Insulin receptor • Guanylyl cyclase receptor enzymes • synthesize cGMP as a 2nd messenger • Atrial natriuretic factor receptor

  10. Insulin receptor • Tyrosine kinase enzyme • Phosphorylates Tyr • Homodimer of ab subunits • a insulin bindingdomain • extracellular • 1 insulin site between the 2 a • b enzyme activity • Spans membrane and intracellular • Both b haveTyr kinase activity when active

  11. Insulin receptor • Insulin binds to a-subunits • b-subunits undergo ‘auto’/cross phosphorylation • b1 phosphorylates b2 and b2 phosphorylates b1 • Conformational change • Kinase is ‘activated’ to phosphorylate other proteins • What does insulin do?

  12. Activated Insulin receptor • Phosphorylation of IRS-1 (insulin-receptor substrate 1) • Docking site for proteins with SH2 domains • IRS-1 binds Grb2 • Has SH3 domain- affinity for prolines • SOS complexes (via SH3) • Binds Ras GDP release and GTP binding • Activates Raf 1 (protein kinase) to phosphorylate MEK (kinase), which phosphorylates ERK (kinase) • ERK enters nucleus and phosphorylates proteins (Elk-1) modulation of insulin-related gene transcription ‘MAP (mitogen activating Pathway) kinase cascade’

  13. Activated Insulin receptor • Phosphorylated IRS-1 • Docking site for proteins with SH2 domains • Binds PI-3K • Converts PIP2 to PIP3 • PIP3 binds to protein kinase B (PKB) • Phosphorylated and activated by PDK1 • Active PKB—2 effects • 1. Stimulates movement of glucose transporters to plasma membrane • 2. Phosphorylates (and inactivates) glycogen synthase kinase 3 (GSK3) • Stimulates glycogen synthesis because glycogen synthase is ‘active’

  14. Steroid/Nuclear receptors • Steroids •  hydrophobic • In serum protein bound • Simple diffusion across membrane • Bind to receptor proteins in nucleus trigger conformational change • 2 domains • Ligand binding domain • DNA binding domain • Modifies gene expression • binds to a regulatory sequence in DNA (hormone response element)

  15. Steroid/Nuclear receptors Stryer ‘Biochemistry’ 2004

  16. Steroid/Nuclear receptors • Agonists • Molecules that bind to receptor and trigger response • Anabolic steroids • Agonists of androgen receptor • Stimulates gene expression lean muscle mass

  17. Steroid/Nuclear receptors • Antagonists • Molecules that bind to receptor but do not trigger response • Like competitive inhibitors (enzymes) • Tamoxifen—estrogen receptor antagonist • Slows growth of cancer cells that depend on estrogen for growth Stryer ‘Biochemistry’ 2004.

More Related